Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ketamine Frequency Treatment for Major Depressive Disorder

NCT00646087 is registered in ClinicalTrials.gov with Essentia Health as lead sponsor.

NCT NCT00646087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00646087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ketamine Frequency Treatment for Major Depressive Disorder
Lead sponsor
Essentia Health
Phase
Phase 4
Overall status
Withdrawn
Start date
March 31, 2008
Completion date
Not reported
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

treatment resistant depression